Stefano Del Prato

56.1k total citations · 14 hit papers
540 papers, 28.7k citations indexed

About

Stefano Del Prato is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Stefano Del Prato has authored 540 papers receiving a total of 28.7k indexed citations (citations by other indexed papers that have themselves been cited), including 334 papers in Endocrinology, Diabetes and Metabolism, 186 papers in Surgery and 156 papers in Molecular Biology. Recurrent topics in Stefano Del Prato's work include Diabetes Treatment and Management (208 papers), Diabetes Management and Research (182 papers) and Metabolism, Diabetes, and Cancer (139 papers). Stefano Del Prato is often cited by papers focused on Diabetes Treatment and Management (208 papers), Diabetes Management and Research (182 papers) and Metabolism, Diabetes, and Cancer (139 papers). Stefano Del Prato collaborates with scholars based in Italy, United States and United Kingdom. Stefano Del Prato's co-authors include Piero Marchetti, Steven E. Kahn, Mark E. Cooper, Ralph A. DeFronzo, R Lupi, Roberto Miccoli, Antonio Tiengo, S Del Guerra, Ugo Boggi and John B. Buse and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stefano Del Prato

522 papers receiving 27.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

2013 1.2k citations Stefano Del Prato et al. profile →
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2022 947 citations Melanie J. Davies, Vanita R. Aroda et al. profile →
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

2021 921 citations Naveed Sattar, Kelley R. Branch et al. profile →
How Do We Define Cure of Diabetes?

2009 753 citations John B. Buse, Stefano Del Prato et al. profile →
COVID-19 in people with diabetes: understanding the reasons for worse outcomes

2020 617 citations Stefano Del Prato et al. profile →
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

2007 586 citations Piero Marchetti, Stefano Del Prato et al. profile →
New-Onset Diabetes in Covid-19

2020 541 citations Geltrude Mingrone, Stefano Del Prato et al. profile →
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2022 532 citations Melanie J. Davies, Vanita R. Aroda et al. Diabetologia profile →
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

2021 503 citations Hertzel C. Gerstein, Naveed Sattar et al. profile →
Management of type 2 diabetes: new and future developments in treatment

2011 429 citations Stefano Del Prato et al. profile →
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

2011 427 citations Stefano Del Prato et al. profile →
COVID-19, Hyperglycemia, and New-Onset Diabetes

2021 184 citations Stefano Del Prato, Chantal Mathieu et al. profile →
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

2022 176 citations Stefano Del Prato, Απόστολος Τσάπας et al. Diabetologia profile →
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics

2023 120 citations John B. Buse, Stefano Del Prato et al. profile →

Peers

Countries citing papers authored by Stefano Del Prato

Since Specialization

Citations

This map shows the geographic impact of Stefano Del Prato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Del Prato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Del Prato more than expected).

Fields of papers citing papers by Stefano Del Prato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Del Prato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Del Prato. The network helps show where Stefano Del Prato may publish in the future.

Co-authorship network of co-authors of Stefano Del Prato

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Del Prato. A scholar is included among the top collaborators of Stefano Del Prato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Del Prato. Stefano Del Prato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management 2025 ·Drugs ·Athena Philis‐Tsimikas, Jens Aberle, Harpreet S. Bajaj, Ildiko Lingvay, Yiming Mu, (unknown), André Gustavo Daher Vianna, Hirotaka Watada, Stefano Del Prato	0
2	GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 2024 ·Acta Diabetologica ·Stefano Ciardullo, Mario Luca Morieri, (unknown), Teresa Vanessa Fiorentino, Teresa Mezza, Domenico Tricò, Agostino Consoli, Stefano Del Prato, Francesco Giorgino, Salvatore Piro, Anna Solini, Angelo Avogaro	9
3	Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial 2024 ·Cardiovascular Diabetology ·James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas H. Marwick, W.H. Wilson Tang, Yuxi Liu, Reza Mohebi, (unknown), Faı̈ez Zannad, Riccardo Perfetti	12
4	Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial 2024 ·Diabetes Obesity and Metabolism ·Matthew P. Gilbert, Joan M. Skelly, Adrian F. Hernandez, Jennifer B. Green, Konstantin A. Krychtiuk, Christopher B. Granger, Lawrence A. Leiter, John J.V. McMurray, Stefano Del Prato, Richard E. Pratley	3
5	Application of SERS Spectroscopy for the Study of Biological Molecules 2023 ·SHILAP Revista de lepidopterología ·(unknown), Stefano Del Prato, (unknown), (unknown), (unknown), Ines Delfino	2
6	The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe 2022 ·Diabetologia ·Chantal Mathieu, (unknown), Stefano Del Prato, (unknown), Xavier Cos, Carine de Beaufort, Jean–François Gautier, (unknown), Angus Forbes, Robert J. Heine, Peter E. H. Schwarz, (unknown), (unknown)	6
7	Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) breakdown → 2022 ·Diabetologia ·Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, Robert A. Gabbay, Jennifer Green, Nisa M. Maruthur, Sylvia E. Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Tsvetalina Tankova, Απόστολος Τσάπας, John B. Buse	532
8	Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial 2021 ·Circulation ·Carolyn S.P. Lam, Chinthanie Ramasundarahettige, Kelley R. Branch, Naveed Sattar, Julio Rosenstock, Richard E. Pratley, Stefano Del Prato, Renato D. Lópes, Elisabeth Niemoeller, Nardev S. Khurmi, Seung Jae Baek, Hertzel C. Gerstein	82
9	Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity 2021 ·International Journal of Obesity ·Giuseppe Daniele, Claudia Lunghi, Angela Dardano, Paola Binda, Giovanni Ceccarini, Ferruccio Santini, Laura Giusti, Annamaria Ciccarone, Rosario Bellini, (unknown), Maria Concetta Morrone, Stefano Del Prato	7
10	MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance. 2021 ·Diabetes & Metabolism ·Cristina Bianchi, Francesco Raggi, Chiara Rossi, Simona Frontoni, Riccardo C. Bonadonna, Stefano Del Prato, Anna Solini	9
11	Interplay between morphology and magnetoelectric coupling in Fe/PMN-PT multiferroic heterostructures studied by microscopy techniques 2020 ·Physical Review Materials ·(unknown), Giovanni Vinai, Valentina Bonanni, Vincent Polewczyk, (unknown), Thomas Forrest, Francesco Maccherozzi, Stefania Benedetti, Christian Rinaldi, M. Cantoni, (unknown), Stefano Del Prato, S. S. Dhesi, G. Rossi, G. Panaccione, Piero Torelli	8
12	Tackling obesity during the COVID‐19 pandemic 2020 ·Diabetes/Metabolism Research and Reviews ·Amit Akirov, Avivit Cahn, Stefano Del Prato, Philip Home, Luc Van Gaal, Juliana C.N. Chan, (unknown), Itamar Raz	3
13	Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 2018 ·Journal of Diabetes and its Complications ·Monia Garofolo, Eleonora Russo, Roberto Miccoli, Daniela Lucchesi, (unknown), (unknown), Giuseppe Daniele, Stefano Del Prato, Giuseppe Penno	13
14	Past continental shelf evolution increased Antarctic ice sheet sensitivity to climatic conditions 2018 ·Scientific Reports ·Florence Colleoni, Laura De Santis, (unknown), (unknown), Christopher C. Sorlien, Philip J. Bart, E. Gasson, A. Bergamasco, (unknown), N. Wardell, Stefano Del Prato	30
15	Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial 2017 ·Journal of Diabetes Investigation ·Ronald C.W., Stefano Del Prato, Baptist Gallwitz, Vyankatesh Shivane, Diane J. Lewis-D’Agostino, Zelie Bailes, Sanjay Patel, Jisoo Lee, Maximilian von Eynatten, (unknown), Stuart A. Ross	11
16	Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin 2013 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Stefano Del Prato	10
17	The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial 2008 ·Diabetic Medicine ·Stefano Del Prato, Lawrence Blonde, L. Martínez, Burkhard Göke, Vincent Woo, Ann Millward, Ramón Gomis, (unknown), Thomas Strack, David Lawrence, Nick Freemantle, (unknown)	11
18	Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients 2007 ·Proceedings of the National Academy of Sciences ·Francesco Dotta, Stefano Censini, Astrid G. S. van Halteren, Lorella Marselli, Matilde Masini, Sabrina Dionisi, Franco Mosca, Ugo Boggi, Andrea Onetti Muda, Stefano Del Prato, John F. Elliott, Antonello Covacci, Rino Rappuoli, Bart O. Roep, Piero Marchetti	419
19	Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man 1994 ·Diabetologia ·Stefano Del Prato, Frida Leonetti, Donald C. Simonson, Peter Sheehan, Masafumi Matsuda, Ralph A. DeFronzo	252
20	Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man 1994 ·Diabetologia ·Stefano Del Prato, Frida Leonetti, (unknown), Peter Sheehan, Masafumi Matsuda, Ralph A. DeFronzo	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact